NGeneBio Co., Ltd. Alternatives & Competitors

12 companies similar to NGeneBio Co., Ltd. — founded in October 2015, developing in vitro diagnostics/companion diagnostics p...

mdxhealth

Molecular Diagnostic Solutions for Prostate Cancer

262 Post-IPO Equity $118.67M

Irvine, United States

Biotechnology Health Care +1

Beaufort CRO

Accelerate your path to market with our global team of MedTech experts.

Virginia Beach, United St...

Biotechnology Medical Devices

Genomtec SA

Molecular diagnosis everywhere, at the right time and for the right price.

26 Grant $26.50M

Poland

Biotechnology Health Care +2

Molbio Diagnostics

588 Venture round $2.49B

Verna, India

Biotechnology Health Care +2

Rival Readout

Competing with NGeneBio Co., Ltd.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Loop Dee Science

Tests you can trust ! Making molecular biology faster and more accessible!

12 Venture round $1.80M

Biotechnology Manufacturing +1

南京普济生物有限公司

德以普济为弘。南京普济生物致力于打造让每位老百姓都用得起的基因检测产品！

3 Angel $100.00M

China

Biotechnology Health Care +1

MNCHIP

16 Series B $33.00M

China

Biotechnology Health Care +1

Qvella Corporation

Microbiology in minutes™

36 $50.04M

Richmond Hill, Canada

Biotechnology Health Care +1

Surmodics, Inc.

To improve the detection and treatment of disease.

304 Post-IPO Debt $125.00M

Eden Prairie, United Stat...

Biotechnology Health Care +2

Rheonix, Inc

Improving standards of care by making molecular diagnostics available to more people, in m...

27 Convertible Note $86.72M

Ithaca, United States

Biotechnology Health Care +2

Biocartis

High precision diagnostics for personalized medicine

314 Grant $322.90M

Mechelen, Belgium

Biotechnology Health Care +1

NovaScan

Easy to use ex vivo and in vivo cancer detection that provides instantaneous, highly accur...

16 Convertible Note $7.48M

Chicago, United States

Biotechnology Health Care +1

About NGeneBio Co., Ltd.

NGeneBio Co., Ltd. is a prominent company in the field of molecular diagnostics (MDx) and companion diagnostics (CDx), specializing in the development of next generation sequencing (NGS)-based in vitro diagnostics (IVD) panels and clinical analysis software (SW). Launched in October 2015 and headquartered in Seoul, Sou...

Business keywords

NGS, Molecular Diagnostics, Companion Diagnostics, Bioinformatics, Clinical Analysis Software, In Vitro Diagnostics, Hereditary Cancer Testing, NGS Panels, SW Development, Genetic Testing, Medical Devices, Cancer Diagnostics, Clinical NGS, BRCA Testing, NGeneBio

Frequently Asked Questions

Companies similar to NGeneBio Co., Ltd. include mdxhealth, Beaufort CRO, Genomtec SA, Molbio Diagnostics, Loop Dee Science. They work in Biotechnology and Medical Devices and share NGeneBio Co., Ltd.'s focus on molecular diagnostics, in vitro diagnostics and genetic testing.

Bounce Watch lists 12 companies that share NGeneBio Co., Ltd.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around NGeneBio Co., Ltd.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

NGeneBio Co., Ltd. Profile mdxhealth Alternatives Beaufort CRO Alternatives Genomtec SA Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at NGeneBio Co., Ltd. on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 14 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.